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Background
Among the second-generation antipsychotics, ziprasidone
seems to be less frequently associated with hyperprol-
actinemia. A MEDLINE search (2002-2006) revealed three
cases of ziprasidone induced hyperprolactinemia. We
describe the case of a patient in whom ziprasidone
induced clinically significant hyperprolactinemia.
Materials and methods
Ms. A, a 22-year old woman, had a 1-year history of para-
noid schizophrenia with delusions and auditory halluci-
nations. Four months ago, she was treated with
ziprasidone 80mg/day. On day 7, the ziprasidone dose
was increased to 160 mg/day, because of insufficient sup-
pression of her psychotic symptoms.
Results
After 5 weeks of ziprasidone treatment, the patient
reported significant improvement of psychotic symptoms.
However, she complained of galactorrhea, breast tender-
ness and amenorrhea. Magnetic resonance imaging (MRI)
of the head showed no pathology, but her prolactin levels
were increased to 47.4 ng/ml. Ziprasidone was discontin-
ued and 3 days after, the patient's prolactin levels were
decreased to 3.7 ng/ml and 2 weeks after clinical side
effects disappeared.
Conclusions
To our knowledge, this is the fourth case of ziprasidone-
induced clinically significant hyperprolactinemia. In this
respect, the clinicians' awareness and the monitoring of
prolactin level are required.
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